Delivery Order SPE2DE24D0013-SPE2D626F02AK
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order (XPRSMVP-10) valued at $2,304.20 under a Defense Logistics Agency Medical Supply Chain Indefinite Delivery Contract. This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 19, 2025, involves the supply of molecular diagnostic products, consistent with Cepheid's core business of providing advanced diagnostic solutions. The contract carries no set-aside...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,800 on January 6, 2026, under a Defense Logistics Agency Medical Supply Chain contract. This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic systems and reagents. The award carries no set-aside designation, reflecting Cepheid's competitive positioning...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,760 by the Defense Logistics Agency Medical Supply Chain on January 9, 2026, with an ultimate completion date of January 16, 2026. This is a child contract under a larger indefinite delivery vehicle, utilizing a firm fixed-price structure with no set-aside designation. The delivery order, identified as XPRSTREPA-10, pertains to diagnostic reagents and test kits for Cepheid's GeneXpert molecular...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $1,597.30 under a Defense Logistics Agency Medical Supply Chain contract (4570223169). This firm fixed-price delivery order, issued on December 9, 2025, with an ultimate completion date of December 16, 2025, represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic solutions. The contract carries no set-aside designation, reflecting Cepheid's...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $5,750.28 under a firm fixed-price contract by the Defense Logistics Agency's Medical Supply Chain on December 22, 2025. This delivery order, with an ultimate completion date of December 30, 2025, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract utilizes no set-aside designation, reflecting Cepheid's competitive...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $20,350 by the Defense Logistics Agency Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 20, 2026. This delivery order, designated as XPRS4PLEX-10, represents a child contract under Cepheid's larger Indefinite Delivery Contract vehicle with the Veterans Health Administration VISN 6, valued at $32.8 million and extending through September 30, 2030. The...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $2,304.20 by the Defense Logistics Agency Medical Supply Chain, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, represents a continuation of Cepheid's ongoing role as a primary federal supplier of molecular diagnostic solutions. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning in the...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,382.52 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. As a leading federal supplier of advanced molecular diagnostic systems and reagents, Cepheid has...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,597.30 by the Defense Logistics Agency's Medical Supply Chain on January 8, 2026, with an ultimate completion date of January 15, 2026. This firm fixed-price delivery order, issued under contract number 4570439578, represents a child contract with no set-aside designation. As a leading manufacturer of advanced molecular diagnostic systems and reagents, Cepheid will deliver diagnostic solutions in...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,024.00 under contract XPRSTREPA-10 by the Defense Logistics Agency's Medical Supply Chain on January 11, 2026, with an ultimate completion date of January 26, 2026. This firm fixed-price delivery order, which is a child contract with no set-aside designation, represents a specific procurement action for diagnostic testing supplies under Cepheid's larger indefinite delivery contract framework with...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F02AKDelivery Order
Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $13,825.20 under a firm fixed-price contract with the Defense Logistics Agency Medical Supply Chain. The delivery order, issued on January 12, 2026, with an ultimate completion date of January 20, 2026, represents a child contract utilizing an existing indefinite delivery vehicle. As a leading federal supplier of molecular diagnostic systems and reagents, Cepheid will deliver diagnostic testing supplies and reagents to support the agency's medical supply chain operations. The contract includes no set-aside designation, reflecting the company's established competitive positioning in federal molecular diagnostics procurement. This delivery order is part of Cepheid's extensive portfolio supporting federal healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. Cepheid specializes in rapid molecular diagnostic testing solutions, particularly its GeneXpert diagnostic platform for detecting infectious diseases including COVID-19, influenza, respiratory syncytial virus, tuberculosis, and other clinical conditions. The company maintains substantial indefinite delivery contracts with the VA, including a $32.8 million agreement with VISN 6 through September 2030 and a $6.7 million contract with VISN 17 through December 2029, demonstrating the VA's reliance on Cepheid as a core supplier of molecular diagnostic capabilities across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 1/11/26 |